GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites
Open accessThe DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Abstract
As the major cause of female anovulatory infertility, polycystic ovary syndrome (PCOS) affects a great proportion of women at childbearing age. Although glucagon-like peptide 1 receptor agonists (GLP-IRAs) show therapeutic effects for PCOS, its target and underlying mechanism remains elusive. In the present study, we identified that, both in vivo and in vitro , GLP-1 functioned as the regulator of proliferation and antiapoptosis of MGCs of follicle in PCOS mouse ovary. Furthermore, forkhead box protein O1 (FoxO1) plays an important role in the courses. Regarding the importance of granulosa cells (GCs) in oocyte development and function, the results from the current study could provide a more detailed illustration on the already known beneficial effects of GLP-1RAs on PCOS and support the future efforts to develop more efficient GLP-1RAs for PCOS treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In PCOS, FOXO1 promotes follicle atresia and granulosa cell apoptosis by activation of pro-apoptotic proteins such as p27Kip1 and Bim, thereby contributing to the cystic changes in the ovaries13,14.”
From Efficacy and safety of GLP-1 receptor agonists on weight management and metabolic parameters in PCOS women: a meta-analysis of randomized controlled trials (2025) · cites this paper as [14]
Experimental — accuracy not yet measuredIn the citing paper
“In this part of the study, the authors demonstrated the GLP-1R was expressed in mural granulosa cells (MGCs), and its expression was decreased in the PCOS model.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
In the citing paper
“The administration of liraglutide significantly attenuated PCOS-associated ovarian MGCs apoptosis in a concentration-dependent manner, and these effects were associated to modifications of the phosphorylation sites of forkhead box protein O1 (FoxO1), a negative regulator of cell survival.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
In the citing paper
“Compared to the placebo group, in the liraglutide group the body weight reduced significantly, and up to 40% mice recovered regular estrous cycles, but testosterone levels were only slightly decreased and the reduction in fasting insulin was not statistically significant.”
From Liraglutide and polycystic ovary syndrome: is it only a matter of body weight? (2023) · cites this paper as [42]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · Fertility and Sterility · doi:10.1016/j.fertnstert.2003.10.004 · Cited by 9,050
The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop group (2004) · Human Reproduction · doi:10.1093/humrep/deh098 · Cited by 6,138 · cited 1×
“-e manifestations of PCOS generally include oligomenorrhea or amenorrhea, abnormal folliculogenesis, chronic anovulation, hyperandrogenemia, and infertility [2].”
BackgroundAzziz, R., Carmina, E., Dewailly, D., Diamanti-Kandarakis, E., Escobar-Morreale, H. F., Futterweit, W., Janssen, O. E., Legro, R. S., Norman, R. J., Taylor, A. E., et al. (2009) · Fertility and Sterility · doi:10.1016/j.fertnstert.2008.06.035 · Cited by 2,132
Dynamic FoxO transcription factors
Huang, H., & Tindall, D. J. (2007) · Journal of Cell Science · doi:10.1242/jcs.001222 · Cited by 1,113
Dijkers, P. F., Medema, R. H., Pals, C., Banerji, L., Thomas, N. S. B., Lam, E. W.-F., Burgering, B. M. T., Raaijmakers, J. A. M., Lammers, J.-W. J., Koenderman, L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9138-9148.2000 · Cited by 617
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604 · cited 1×
“Given that phosphorylation modification is an important regulator of FoxO1 transcriptional activity [24].”
BackgroundFollicle dynamics and anovulation in polycystic ovary syndrome
Franks, S., Stark, J., & Hardy, K. (2008) · Human Reproduction Update · doi:10.1093/humupd/dmn015 · Cited by 581 · cited 1×
“Also, GCs apoptosis-induced follicular atresia is the main cause of failure in dominant follicle selection [27].”
BackgroundGlucagon-like peptide 1 in health and disease
Andersen, A., Lund, A., Knop, F. K., & Vilsbøll, T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0016-2 · Cited by 543
Oocyte competence in women with polycystic ovary syndrome
Palomba, S., Daolio, J., & La Sala, G. B. (2017) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2016.11.008 · Cited by 294 · cited 2×
“PCOS is the most frequent cause of female anovulatory infertility [3].”
BackgroundRecent updates on GLP-1 agonists: Current advancements & challenges
Sharma, D., Verma, S., Vaidya, S., Kalia, K., & Tiwari, V. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.08.088 · Cited by 265 · cited 1×
“GLP1 is an incretin hormone that exhibits several pharmacological actions such as neuroprotection, increased cognitive function, cardioprotection, decreased hypertension, suppression of acid secretion, and protection from inflammation [29].”
Background
Research works printed but not linked: 2
- 10.1210/mend.16.3.0806 · doi:10.1210/mend.16.3.0806 · Paper page
- 2017, American Journal of Cancer Research, 7, 1476
Cited by
GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
Zhao, X., Wang, M., Wen, Z., Lu, Z., Cui, L., Fu, C., Xue, H., Liu, Y., & Zhang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.721135 · Cited by 463
Zhou, L., Qu, H., Yang, L., & Shou, L. (2023) · BMC Endocrine Disorders · doi:10.1186/s12902-023-01500-5 · Cited by 66
“Sun et al. reported the contribution of GLP-1 to the regulation of ovarian granulosa cells proliferation and antiapoptosis, thereby promoting oocyte maturation in PCOS rats [53].”
BackgroundAbdalla, M. A., Deshmukh, H., Atkin, S., & Sathyapalan, T. (2021) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018821989238 · Cited by 60
Lin, S., Deng, Y., Huang, J., Li, M., Sooranna, S. R., Qin, M., & Tan, B. (2025) · Scientific Reports · doi:10.1038/s41598-025-99622-4 · Cited by 35
Chauvin, S. (2025) · Biomolecules · doi:10.3390/biom15070923 · Cited by 39
“In PCOS mouse models, GLP-1RAs have partially restored estrous cyclicity and improved MGC proliferation, partly through the inactivation of the pro-apoptotic FOXO1 [179].”
Metadata
- Authors
- Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J.
- Affiliations
- Third Affiliated Hospital of Southern Medical University (CN)
- Southern Medical University (CN)
- Corresponding author
- Shen, Jie
- Venue
- International Journal of Endocrinology
- Publisher
- Wiley
- Published
- 2020-06-19
- Volume
- 2020
- Pages
- 1-10
- ISSN
- 1687-8337 (ISSN-L)
- 1687-8345
- PMC
- PMC7321515
- OpenAlex
- W3036323776
- Cited by
- 37
- References
- 42
- Citations by year
- 2026: 6 · 2025: 13 · 2024: 5 · 2023: 7 · 2022: 3 · 2021: 3
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- International Journal of Endocrinology (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Natural Science Foundation of Guangdong Province (2018A030313997, A2019186, 2017-Z04-35)
- Guangdong Medical Science and Technology Research Fund Project (2018A030313997, A2019186, 2017-Z04-35)
- Science and Technology Program of Panyu District (2018A030313997, A2019186, 2017-Z04-35)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic and Kidney Cyst Diseases
- Keywords
- polycystic ovary syndrome, glucagon-like peptide-1, GLP-1 receptor agonists, granulosa cells, FOXO1 phosphorylation, cell proliferation, apoptosis, oogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites. https://app.cochat.ai/papers/10.1155/2020/1484321
- The paper
- Sun, Z., Li, P., Wang, X., Lai, S., Qiu, H., Chen, Z., Hu, S., Yao, J., & Shen, J. (2020). GLP-1/GLP-1R Signaling Regulates Ovarian PCOS-Associated Granulosa Cells Proliferation and Antiapoptosis by Modification of Forkhead Box Protein O1 Phosphorylation Sites. International Journal of Endocrinology. https://doi.org/10.1155/2020/1484321
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.